| 1 |
Functional identification of factor VIII B domain regions in hepatocyte cells
Zhang J, Lin MM, Zhang QQ, Wang YH, Zhu CY, Li X
Biochemical and Biophysical Research Communications, 526(3), 633, 2020 |
| 2 |
Targeting of the human F8 at the multicopy rDNA locus in Hemophilia a patient-derived iPSCs using TALENickases
Pang JL, Wu Y, Li Z, Hu ZQ, Wang XL, Hu XY, Wang XY, Liu XH, Zhou MJ, Liu B, Wang YC, Feng M, Liang DS
Biochemical and Biophysical Research Communications, 472(1), 144, 2016 |
| 3 |
BAY 81-8973, a full-length recombinant factor VIII: Human heat shock protein 70 improves the manufacturing process without affecting clinical safety
Enriquez MM, Thrift J, Garger S, Katterle Y
Protein Expression and Purification, 127, 111, 2016 |
| 4 |
Role of hydrophobic mutations on the binding affinity and stability of blood coagulation factor VIIIa: A computational molecular dynamics and free-energy analysis
Venkateswarlu D
Biochemical and Biophysical Research Communications, 450(1), 735, 2014 |
| 5 |
An induced pluripotent stem cell-mediated and integration-free factor VIII expression system
Yakura Y, Ishihara C, Kurosaki H, Kazuki Y, Komatsu N, Okada Y, Doi T, Takeya H, Oshimura M
Biochemical and Biophysical Research Communications, 431(2), 336, 2013 |
| 6 |
Insect cell-based expression and characterization of a single-chain variable antibody fragment directed against blood coagulation factor VIII
Kurasawa JH, Shestopal SA, Jha NK, Ovanesov MV, Lee TK, Sarafanov AG
Protein Expression and Purification, 88(2), 201, 2013 |
| 7 |
Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGE
Monetti C, Rottensteiner H, Gritsch H, Weber A, Scheiflinger F, Turecek PL
Electrophoresis, 32(11), 1292, 2011 |
| 8 |
Plasma-derived clotting factor VIII: Heterogeneity evaluation in the quest for potential inhibitory-antibody stimulating factors
D'Amici GM, Blasi B, D'Alessandro A, Vaglio S, Zolla L
Electrophoresis, 32(21), 2941, 2011 |
| 9 |
Recombinant clotting factor VIII concentrates: Heterogeneity and high-purity evaluation
D'Amici GM, Timperiol AM, Gevi F, Grazzini G, Zolla L
Electrophoresis, 31(16), 2730, 2010 |
| 10 |
The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy
Shen YJ, Yin J
Biotechnology Letters, 31(3), CP7, 2009 |
